Published in Drug Law Weekly, November 20th, 2007
Of the more than 2,000 heart transplants performed each year in the United States, up to 20 percent of the patients die or reject their organ within a year due to right heart failure brought on by pulmonary hypertension, infection or immune response.
In a study to be presented Nov. 6 at the American Heart Associationís (AHA) annual Scientific Sessions in Orlando, Fla., the Hopkins team found that transplant recipients who needed and got commonly used...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly